ArticleInternal and emergency medicine2026
Hypocholesterolemia as a predictor of mortality in infective endocarditis.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infective endocarditis (IE) is a thrombo-inflammatory disorder affecting the endocardium, showing a high morbidity and mortality. Circulating cholesterol levels generally decrease in severe infections but have not been analyzed in depth in IE. This was a single-center retrospective observational study including IE patients admitted between 2016 and 2023. After drawing ROC curves of lipid profile components for mortality, variables of interest were compared among two subgroups, determined by the best predictor's cut-off value, using univariable and multivariable models. An adjusted logistic regression for in-hospital mortality was performed after inverse probability of treatment weighting. Survival analysis was carried out by the Kaplan-Meier method. Two-hundred-seventy-eight patients were included. Total cholesterol (TC) showed the highest AUROC for mortality (0.713 [0.625-0.801]). Patients with lower TC levels (≤ 134.5 mg/dL) were more likely to have ischemic heart disease (p = 0.026) and a higher creatinine (p = 0.006). Ischemic heart disease was an independent predictor of low TC levels (O.R. 2.190 [1.110-4.470]). The adjusted logistic regression showed a significantly higher risk of death during hospitalization in patients with lower TC levels (aOR 2.94, [1.80-4.92], p < 0.001). Survival analysis confirmed a higher in-hospital (p = 0.003) and 1-year (p < 0.001) mortality in patients with lower TC levels. Results of this study suggest that TC levels are strongly associated with in-hospital and 1-year mortality in IE. A cut-off for TC of 134.5 mg/dL was able to identify those at very low risk of death. Multicenter, prospective studies are needed to validate use of TC as a readily available and inexpensive marker of prognosis.
Indexed as
Identifiers
42397526What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.